139 related articles for article (PubMed ID: 25035225)
1. Stereotactic ablative therapy and the central chest: in regard to Oskan.
Lo SS; Huang Z; Yuh WT; Mayr NA
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1143. PubMed ID: 25035225
[No Abstract] [Full Text] [Related]
2. Does reluctance to deliver stereotactic body radiation therapy to the central chest result from meaningful inference?
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):975-7. PubMed ID: 24606860
[No Abstract] [Full Text] [Related]
3. In reply to Lo et al.
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1143-1144. PubMed ID: 25035224
[No Abstract] [Full Text] [Related]
4. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
Karlsson K; Nyman J; Baumann P; Wersäll P; Drugge N; Gagliardi G; Johansson KA; Persson JO; Rutkowska E; Tullgren O; Lax I
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):590-5. PubMed ID: 24074933
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
8. Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?
Stanford-Edwards C; Edwards M; Selby A; Lewis R; Powell C; Nicholas O
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):e105-e106. PubMed ID: 34895991
[No Abstract] [Full Text] [Related]
9. Pulmonary atelectasis after stereotactic ablative radiotherapy for a central lung tumor.
Senthi S; Ullmann EF; Senan S
J Thorac Oncol; 2013 Nov; 8(11):e94-5. PubMed ID: 24128724
[No Abstract] [Full Text] [Related]
10. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
Park Y; Kim HJ; Chang AR
Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
12. Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
Tsang MW; Kam MK; Leung SF; Chan AT
Hong Kong Med J; 2014 Dec; 20(6):529-36. PubMed ID: 25256817
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.
Cannon NA; Iyengar P; Choy H; Timmerman R; Meyer J
BMC Cancer; 2014 Dec; 14():971. PubMed ID: 25518879
[TBL] [Abstract][Full Text] [Related]
15. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic ablative radiation therapy for primary lung tumors.
Heinzerling JH; Kavanagh B; Timmerman RD
Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for lung tumors: system-related issues and complications.
Gaspar LE
Clin Lung Cancer; 2007 Jan; 8(4):233. PubMed ID: 17311686
[No Abstract] [Full Text] [Related]
18. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222
[No Abstract] [Full Text] [Related]
19. Central-airway necrosis after stereotactic body-radiation therapy.
Corradetti MN; Haas AR; Rengan R
N Engl J Med; 2012 Jun; 366(24):2327-9. PubMed ID: 22694017
[No Abstract] [Full Text] [Related]
20. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
